Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BUCCOLAM OROMUCOSAL SOLUTION - Special Drug Use Surveillance

NCT05313308 is registered in ClinicalTrials.gov with Clinigen K.K. as lead sponsor.

NCT NCT05313308
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05313308 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BUCCOLAM OROMUCOSAL SOLUTION - Special Drug Use Surveillance
Lead sponsor
Clinigen K.K.
Phase
Observational
Overall status
Recruiting
Start date
June 1, 2021
Completion date
August 31, 2028
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy